Literature DB >> 18083240

TNF and sTNFR1/2 plasma levels in ALS patients.

Cristina Cereda1, Chiara Baiocchi, Paolo Bongioanni, Emanuela Cova, Stefania Guareschi, Maria Rita Metelli, Bruno Rossi, Ilaria Sbalsi, Maria Clara Cuccia, Mauro Ceroni.   

Abstract

The involvement of the immune system has been hypothesized in the pathogenesis of amyotrophic lateral sclerosis (ALS). In this study a significantly higher level of TNF-alpha and its soluble receptors, TNF-R1 and TNF-R2, has been found in plasma of patients affected by the sporadic form of ALS compared to normal subjects. The genetic analysis of the polymorphisms of TNF-alpha, TNF-R1 and TNF-R2 showed no statistically significant differences in alleles and genotype frequencies between patients and controls. These data suggest a participation of the immune system in response to as far unknown intracellular signals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18083240     DOI: 10.1016/j.jneuroim.2007.10.028

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  42 in total

1.  Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS).

Authors:  Rongzhen Zhang; Kenneth G Hadlock; Hien Do; Stephanie Yu; Ronald Honrada; Stacey Champion; Dallas Forshew; Catherine Madison; Jonathan Katz; Robert G Miller; Michael S McGrath
Journal:  J Neuroimmunol       Date:  2010-09-29       Impact factor: 3.478

2.  IL-27 inhibits OSM-mediated TNF-alpha and iNOS gene expression in microglia.

Authors:  Brandi J Baker; Keun W Park; Hongwei Qin; Xiangyu Ma; Etty N Benveniste
Journal:  Glia       Date:  2010-07       Impact factor: 7.452

Review 3.  Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.

Authors:  Lucas T Vu; Robert Bowser
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

Review 4.  Motor neuron-immune interactions: the vicious circle of ALS.

Authors:  Ana G Barbeito; Pinar Mesci; Séverine Boillée
Journal:  J Neural Transm (Vienna)       Date:  2010-06-15       Impact factor: 3.575

5.  Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes.

Authors:  Weihua Zhao; David R Beers; Kristopher G Hooten; Douglas H Sieglaff; Aijun Zhang; Shanker Kalyana-Sundaram; Christopher M Traini; Wendy S Halsey; Ashley M Hughes; Ganesh M Sathe; George P Livi; Guo-Huang Fan; Stanley H Appel
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

6.  Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trial.

Authors:  Elijah W Stommel; Jeffrey A Cohen; Camilo E Fadul; Christopher H Cogbill; David J Graber; Linda Kingman; Todd Mackenzie; Jacqueline Y Channon Smith; Brent T Harris
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

7.  Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS).

Authors:  Rongzhen Zhang; Robert G Miller; Ron Gascon; Stacey Champion; Jonathan Katz; Mariselle Lancero; Amy Narvaez; Ronald Honrada; David Ruvalcaba; Michael S McGrath
Journal:  J Neuroimmunol       Date:  2008-11-14       Impact factor: 3.478

8.  NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker study.

Authors:  Robert G Miller; Rongzhen Zhang; Gilbert Block; Jonathan Katz; Richard Barohn; Edward Kasarskis; Dallas Forshew; Vidhya Gopalakrishnan; Michael S McGrath
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-09-05       Impact factor: 4.092

Review 9.  Signaling by death receptors in the nervous system.

Authors:  Georg Haase; Brigitte Pettmann; Cédric Raoul; Christopher E Henderson
Journal:  Curr Opin Neurobiol       Date:  2008-06       Impact factor: 6.627

10.  Evaluation of Peripheral Immune Activation in Amyotrophic Lateral Sclerosis.

Authors:  Mengli Wang; Zhen Liu; Juan Du; Yanchun Yuan; Bin Jiao; Xuewei Zhang; Xuan Hou; Lu Shen; Jifeng Guo; Hong Jiang; Kun Xia; Jianguang Tang; Ruxu Zhang; Beisha Tang; Junling Wang
Journal:  Front Neurol       Date:  2021-06-24       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.